Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 03 Apr 2024

Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder: a 17-year follow-up on the LiSIE retrospective cohort study

in Psychopharmacology

Petra Truedson
Michael Ott
Lisa Wahlström
Robert Lundqvist
Martin Maripuu
Krister Lindmark
Ingrid Lieber
Ursula Werneke

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1358461

2,542 views
1 citation

General Commentary

Published on 25 Mar 2024

Commentary: Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

in Psychopharmacology

Tycho J. Dekkers

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1383492

4,246 views
1 citation

Case Report

Published on 19 Mar 2024

Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics

in Psychopharmacology

Liam Korošec Hudnik
Tanja Blagus
Sara Redenšek Trampuž
Vita Dolžan
Jurij Bon
Milica Pjevac

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1363051

3,726 views
4 citations

Systematic Review

Published on 08 Mar 2024

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

in Psychopharmacology

Alexandros Matsingos
Marcel Wilhelm
Laila Noor
Cüneyt Yildiz
Winfried Rief
Stefan G. Hofmann
Irina Falkenberg
Tilo Kircher

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1346697

5,929 views
12 citations

Editorial

Published on 28 Feb 2024

Editorial: Reviews in psychiatry 2022: psychopharmacology

in Psychopharmacology

Maris Taube

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1382027

1,509 views

Original Research

Published on 22 Feb 2024

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey

in Psychopharmacology

Nicolas G. Glynos
Jacob S. Aday
Daniel Kruger
Kevin F. Boehnke
Stephanie Lake
Philippe Lucas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1349565

6,284 views
7 citations

Case Report

Published on 20 Feb 2024

Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy

in Psychopharmacology

Christopher P. Harris
Becky Jones
Kathryn Walker
Meredith S. Berry

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322679

6,124 views

Brief Research Report

Published on 19 Feb 2024

Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression

in Psychopharmacology

Aleksander Kwaśny
Wiesław Jerzy Cubała
Adam Włodarczyk

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1334293

3,607 views
3 citations

Case Report

Published on 07 Feb 2024

Hypothyroidism and sinus dysfunction associated with lithium-paliperidone combination therapy for bipolar disorder with psychotic symptoms: a case report

in Psychopharmacology

Wenjian Wei
Yonglan Yang
Haifeng Wang
Yunbin Yang
Jizhou Liu
Jinfeng Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1336100

2,416 views
1 citation

Systematic Review

Published on 05 Feb 2024

Keeping the promise: a critique of the current state of microdosing research

in Psychopharmacology

Rotem Petranker
Thomas Anderson
Emily C. Fewster
Youval Aberman
Marik Hazan
Michael Gaffrey
Paul Seli

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1217102

6,352 views
7 citations

Hypothesis and Theory

Published on 01 Feb 2024

Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach

in Psychopharmacology

Phil Wolfson
Gita Vaid

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1209419

13,695 views
7 citations

Editorial

Published on 24 Jan 2024

Editorial: Case reports in psychopharmacology

in Psychopharmacology

Matej Stuhec
Patricia Di Ciano

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1364711

1,351 views

Original Research

Published on 23 Jan 2024

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety

in Psychopharmacology

Johannes Hauser
Jan Sarlon
Timur Liwinski
Annette B. Brühl
Undine E. Lang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1327598

4,910 views
4 citations

Original Research

Published on 17 Jan 2024

The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents

in Psychopharmacology

Isabel Hach
Thomas Bertsch
Patrick Nonell

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1240681

2,442 views

Clinical Trial

Published on 16 Jan 2024

Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial

in Psychopharmacology

Seyed Shahab Banihashem
Seyedeh Mahsa Mofatioshieh
Reyhaneh Rastegar
Amir Sadeghi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1297231

7,484 views
5 citations

Original Research

Published on 11 Jan 2024

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

in Psychopharmacology

Ellen James
David Erritzoe
Tiffanie Benway
Zelah Joel
Christopher Timmermann
Meghan Good
Claudio Agnorelli
Brandon M. Weiss
Tommaso Barba
Graham Campbell

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1305796

5,434 views
7 citations